Pacli Injection 6 mg/ml contains Paclitaxel, a potent antineoplastic agent widely used in the treatment of various solid tumors. Paclitaxel belongs to the taxane class of chemotherapeutic drugs and plays a critical role in modern oncology by inhibiting cancer cell division. Pacli Injection is administered intravenously under specialist supervision and is commonly included in combination chemotherapy regimens for improved therapeutic outcomes.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Composition

• Active ingredient: Paclitaxel 6 mg/ml

• Dosage form: Sterile intravenous injection

Therapeutic Class

• Taxane antineoplastic agent

• Microtubule inhibitor

Mechanism of Action

Paclitaxel works by promoting the assembly of microtubules and stabilizing them against depolymerization. This action prevents the normal breakdown of microtubules required for cell division, effectively arresting cancer cells in the mitotic phase of the cell cycle. As a result, Pacli Injection inhibits tumor cell proliferation and induces programmed cell death. Its mechanism selectively targets rapidly dividing cancer cells, making it effective against a wide range of malignancies.

Indications

Pacli Injection 6 mg/ml is indicated for the treatment of several cancers, including:

• Ovarian cancer, as first-line or subsequent therapy

• Breast cancer, including metastatic disease

• Non-small cell lung cancer (NSCLC), often in combination with platinum-based agents

• AIDS-related Kaposi’s sarcoma

• Other solid tumors as recommended by an oncologist

Dosage and Administration

• Pacli Injection is administered by intravenous infusion under the supervision of a qualified healthcare professional.

• The dosage and infusion schedule depend on the type of cancer, patient body surface area, and treatment protocol.

• Premedication with corticosteroids, antihistamines, and H2 antagonists is recommended to reduce the risk of hypersensitivity reactions.

• Dose modifications may be necessary based on blood counts, liver function, and patient tolerance.

Benefits and Features

• Broad-spectrum antineoplastic activity

• Effective in multiple solid tumors

• Often used in combination regimens for enhanced efficacy

• Well-established role in standard chemotherapy protocols

• Administered in controlled clinical settings for patient safety

Precautions and Warnings

• Severe hypersensitivity reactions may occur; premedication is essential.

• Bone marrow suppression is common; regular monitoring of complete blood counts is required.

• Use with caution in patients with hepatic impairment.

• Peripheral neuropathy may develop with prolonged use.

• Not recommended during pregnancy or breastfeeding unless clearly justified by the treating physician.

  রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Side Effects

Common side effects include neutropenia, anemia, alopecia, nausea, vomiting, diarrhea, peripheral neuropathy, myalgia, and arthralgia. Serious adverse reactions may include severe infections, hypersensitivity reactions, and cardiac conduction abnormalities.

Storage

• Store below 25°C

• Protect from light

• Do not freeze

• Keep out of reach of children

Pacli Injection 6 mg/ml is a cornerstone chemotherapeutic agent in the management of several malignancies. When administered under expert medical supervision, it contributes significantly to tumor control, improved survival outcomes, and integrated cancer care.